RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 42 filers reported holding RENEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,043 | -78.6% | 531 | -81.6% | 0.00% | – |
| Q2 2023 | $18,906 | -24.4% | 2,882 | -61.5% | 0.00% | – |
| Q3 2022 | $25,000 | +19.0% | 7,495 | -4.9% | 0.00% | – |
| Q2 2022 | $21,000 | +950.0% | 7,879 | +936.7% | 0.00% | – |
| Q1 2022 | $2,000 | -90.9% | 760 | -71.1% | 0.00% | – |
| Q4 2021 | $22,000 | +144.4% | 2,629 | +127.4% | 0.00% | – |
| Q3 2021 | $9,000 | +200.0% | 1,156 | +285.3% | 0.00% | – |
| Q2 2021 | $3,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $7,083,000 | 7.27% |
| Abingworth LLP | 2,073,957 | $6,077,000 | 1.72% |
| Aisling Capital Management LP | 886,075 | $2,605,000 | 1.41% |
| Novo Holdings A/S | 3,430,377 | $10,085,000 | 0.53% |
| NEA Management Company, LLC | 4,786,921 | $14,073,000 | 0.41% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 700,000 | $2,058,000 | 0.12% |
| Rock Springs Capital Management LP | 1,143,185 | $3,361,000 | 0.08% |
| Ikarian Capital, LLC | 185,597 | $546,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $294,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,648 | $52,000 | 0.00% |